Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Adalimumab-afzb Injection (Abrilada) in shortage?

Adalimumab-afzb Injection is listed by FDA as being discontinued by at least one maker (updated Oct 9, 2025).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Abrilada, Injection, Kit (NDC 0025-0325-01)
    Pfizer Inc.Being discontinuedUpdated Oct 9, 2025Discontinued Oct 9, 2025

    Discontinuation of the manufacture of the drug

    Maker contact: 800-646-4398

Adalimumab-afzb Injection shortage questions

Is Adalimumab-afzb Injection (Abrilada) in shortage?

Adalimumab-afzb Injection is listed by FDA as being discontinued by at least one maker (updated Oct 9, 2025).

What should I do if I can’t get Adalimumab-afzb Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.